Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, April 23, 2025 (GLOBE NEWSWIRE) -- The "GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030" has been added to ResearchAndMarkets.com's offering. The Gulf Cooperation...
-
Actum Pharma Expands Executive Team to Launch Enhanced Services Program to Support Biopharma Product Commercialization and Market Success
-
AscellaHealth Announces Key Executive Promotions, Supporting Strategic Growth in the Life Sciences Business Unit
-
Optime Care has expanded partnership with Eton Pharmaceuticals to serve as the SP provider for GALZIN®, an FDA-approved treatment for Wilson Disease.
-
TEMECULA, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, is pleased to...
-
Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering. The Gulf...
-
Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Specialty Pharmaceuticals Market by Type, Product, Distribution Channel - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's...
-
BERWYN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today released its latest...
-
Optime Care Broadens Partnership with Rigel Pharmaceuticals for Expanded Commercial Distribution of TAVALISSE®
-
TEMECULA, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, celebrates 13,151...